Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.

BACKGROUND: Glucokinase (GCK) is the key glucose phosphorylation enzyme which has attracted considerable attention as a candidate gene for type 2 diabetes (T2D) based on its enzyme function as the first rate-limiting step in the glycolysis pathway and regulates glucose-stimulated insulin secretion....

Full description

Bibliographic Details
Main Authors: Da Fu, Xianling Cong, Yushui Ma, Haidong Cai, Mingxiang Cai, Dan Li, Mingli Lv, Xueyu Yuan, Yinghui Huang, Zhongwei Lv
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3575415?pdf=render
id doaj-4aefc8118c88411e90b97f9c888459aa
record_format Article
spelling doaj-4aefc8118c88411e90b97f9c888459aa2020-11-25T02:42:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5572710.1371/journal.pone.0055727Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.Da FuXianling CongYushui MaHaidong CaiMingxiang CaiDan LiMingli LvXueyu YuanYinghui HuangZhongwei LvBACKGROUND: Glucokinase (GCK) is the key glucose phosphorylation enzyme which has attracted considerable attention as a candidate gene for type 2 diabetes (T2D) based on its enzyme function as the first rate-limiting step in the glycolysis pathway and regulates glucose-stimulated insulin secretion. In the past decade, the relationship between GCK and T2D has been reported in various ethnic groups. To derive a more precise estimation of the relationship and the effect of factors that might modify the risk, we performed this meta-analysis. METHODS: Databases including Pubmed, EMBASE, Web of Science and China National Knowledge Infrastructure (CNKI) were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. RESULTS: A total of 24 articles involving 88,229 cases and 210,239 controls were included. An overall random-effects per-allele OR of 1.06 (95% CI: 1.03-1.09; P<10(-4)) was found for the GCK -30G>A polymorphism. Significant results were also observed using dominant or recessive genetic models. In the subgroup analyses by ethnicity, significant results were found in Caucasians; whereas no significant associations were found among Asians. In addition, we found that the -30G>A polymorphism is a risk factor associated with increased impaired glucose regulation susceptibility. Besides, -30G>A homozygous was found to be significantly associated with increased fasting plasma glucose level with weighted mean difference (WMD) of 0.15 (95%: 0.05-0.24, P = 0.001) compared with G/G genotype. CONCLUSIONS: This meta-analysis demonstrated that the -30G>A polymorphism of GCK is a risk factor associated with increased T2D susceptibility, but these associations vary in different ethnic populations.http://europepmc.org/articles/PMC3575415?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Da Fu
Xianling Cong
Yushui Ma
Haidong Cai
Mingxiang Cai
Dan Li
Mingli Lv
Xueyu Yuan
Yinghui Huang
Zhongwei Lv
spellingShingle Da Fu
Xianling Cong
Yushui Ma
Haidong Cai
Mingxiang Cai
Dan Li
Mingli Lv
Xueyu Yuan
Yinghui Huang
Zhongwei Lv
Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
PLoS ONE
author_facet Da Fu
Xianling Cong
Yushui Ma
Haidong Cai
Mingxiang Cai
Dan Li
Mingli Lv
Xueyu Yuan
Yinghui Huang
Zhongwei Lv
author_sort Da Fu
title Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
title_short Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
title_full Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
title_fullStr Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
title_full_unstemmed Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
title_sort genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND: Glucokinase (GCK) is the key glucose phosphorylation enzyme which has attracted considerable attention as a candidate gene for type 2 diabetes (T2D) based on its enzyme function as the first rate-limiting step in the glycolysis pathway and regulates glucose-stimulated insulin secretion. In the past decade, the relationship between GCK and T2D has been reported in various ethnic groups. To derive a more precise estimation of the relationship and the effect of factors that might modify the risk, we performed this meta-analysis. METHODS: Databases including Pubmed, EMBASE, Web of Science and China National Knowledge Infrastructure (CNKI) were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. RESULTS: A total of 24 articles involving 88,229 cases and 210,239 controls were included. An overall random-effects per-allele OR of 1.06 (95% CI: 1.03-1.09; P<10(-4)) was found for the GCK -30G>A polymorphism. Significant results were also observed using dominant or recessive genetic models. In the subgroup analyses by ethnicity, significant results were found in Caucasians; whereas no significant associations were found among Asians. In addition, we found that the -30G>A polymorphism is a risk factor associated with increased impaired glucose regulation susceptibility. Besides, -30G>A homozygous was found to be significantly associated with increased fasting plasma glucose level with weighted mean difference (WMD) of 0.15 (95%: 0.05-0.24, P = 0.001) compared with G/G genotype. CONCLUSIONS: This meta-analysis demonstrated that the -30G>A polymorphism of GCK is a risk factor associated with increased T2D susceptibility, but these associations vary in different ethnic populations.
url http://europepmc.org/articles/PMC3575415?pdf=render
work_keys_str_mv AT dafu geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT xianlingcong geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT yushuima geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT haidongcai geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT mingxiangcai geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT danli geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT minglilv geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT xueyuyuan geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT yinghuihuang geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
AT zhongweilv geneticpolymorphismofglucokinaseontheriskoftype2diabetesandimpairedglucoseregulationevidencebasedon298468subjects
_version_ 1724772659577749504